Our vision is to defeat cancer and advance health equity for ALL communities through patient-centric social innovation and intentional, mission-aligned impact investing.

BrightEdge exists to accelerate the American Cancer Society's goal to reduce cancer mortality, end pain and suffering, and advance health equity Learn how BrightEdge will help improve 1.5 million lives by investing in cancer-focused therapies and technologies in its most recent annual report and infographic.


BrightEdge Entrepreneurs Program: Winners Will Be Announced on January 5, 2024

The BrightEdge Entrepreneurs (BEE) program is the first cancer-focused, geography-agnostic, early-stage venture accelerator offering access to training, experts, resources & capital. This inaugural program is aimed at supporting and training emerging bioentrepreneurs to accelerate research discoveries for the benefit of patients.

Investing for science, social impact, and sustainability

BrightEdge invests in entrepreneurial early-stage companies developing cutting-edge cancer-focused therapeutics, diagnostics, devices, and technologies to bring innovative solutions to market.


Fighting for a World Without Cancer

BrightEdge is led by a world-class team of investors, operators, and entrepreneurs to accelerate the commercialization of the breadth of solutions needed to target cancer from all perspectives.